Application no. and date | 02780626.4 (espacenet) (Federated) (European Patent Register), 20021025 | Patent/reg. no. and date | DK/EP 1441771, 20080910 | Publication date | 20040804 | Priority no. and date | US 37369, 20011107 | EP pub. no. and date |
EP 1441771 20040804 | Effective date | | Applicant/owner | Ortho-McNeil-Janssen Pharmaceuticals, Inc., 1125 Trenton-Harbourton Road
Titusville NJ 08560, US | Applicant ref. no. | 134122 | Inventor | SHARMA, Basant, 837 Bluestone Lane
Bridgewater, NJ 08807, US, JIN, Renzhe, 44 McBride Way
Bridgewater, NJ 08807, US, RUDOLPH, Sunitha, 3820 West Brandon Way
Doylestown, PA 18901, US, CHEUNG, Wing, K., 21 Crosswood Way
Warren, NJ 07059, US, BEGUM, Selima, 10 Sandalwood Drive
Edison, NJ 08820, US, KELLEY, Marian, 21 John Drive
Annandale, NJ 08801, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 38/18 (2006.01) , A61K 47/38 (2006.01) | Title | Vandige proteinformuleringer med opreholdt frigivelse | Int. application no. | US2002036300 | Int. publication no. | WO2003053471 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|